"
Team:GeorgiaTech/Abstract
From 2011.igem.org
(Difference between revisions)
| Line 10: | Line 10: | ||
<center><b>Abstract:</b></center> | <center><b>Abstract:</b></center> | ||
<br> | <br> | ||
| - | The ultimate goal of our project was to utilize this system as a mobile gene targeting system capable of eliminating antibiotic resistance. The protoype construct, pSTINGER, was designed for quantitative modeling, proof of concept, and vaccination on a single plasmid. As a result of experimental error, intellectual property agreements, material availability, our biobrick constructs remain experimentally theoretical, though we have modeled our system in various scenarios. | + | The ultimate goal of our project was to utilize this system as a mobile gene targeting system capable of eliminating antibiotic resistance. The protoype construct, pSTINGER, was designed for quantitative modeling, proof of concept, and vaccination on a single plasmid. As a result of experimental error, intellectual property agreements, material availability, our biobrick constructs remain experimentally theoretical, though we have rigorously modeled our system in various scenarios. |
</font> | </font> | ||
</head> | </head> | ||
</html> | </html> | ||
Latest revision as of 03:44, 29 September 2011
The ultimate goal of our project was to utilize this system as a mobile gene targeting system capable of eliminating antibiotic resistance. The protoype construct, pSTINGER, was designed for quantitative modeling, proof of concept, and vaccination on a single plasmid. As a result of experimental error, intellectual property agreements, material availability, our biobrick constructs remain experimentally theoretical, though we have rigorously modeled our system in various scenarios.
